These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 20029174)

  • 1. Management of chronic childhood immune thrombocytopenic purpura: AIEOP consensus guidelines.
    De Mattia D; Del Vecchio GC; Russo G; De Santis A; Ramenghi U; Notarangelo L; Jankovic M; Molinari AC; Zecca M; Nobili B; Giordano P;
    Acta Haematol; 2010; 123(2):96-109. PubMed ID: 20029174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute childhood idiopathic thrombocytopenic purpura: AIEOP consensus guidelines for diagnosis and treatment. Associazione Italiana di Ematologia e Oncologia Pediatrica.
    De Mattia D; Del Principe D; Del Vecchio GC; Jankovic M; Arrighini A; Giordano P; Menichelli A; Mori P; Zecca M; Pession A
    Haematologica; 2000 Apr; 85(4):420-4. PubMed ID: 10756369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
    Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of adult idiopathic thrombocytopenic purpura.
    Nakhoul IN; Kozuch P; Varma M
    Clin Adv Hematol Oncol; 2006 Feb; 4(2):136-44, 153. PubMed ID: 16728922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of acute childhood idiopathic thrombocytopenic purpura according to AIEOP consensus guidelines: assessment of Italian experience.
    Del Vecchio GC; De Santis A; Giordano P; Amendola G; Baronci C; Del Principe D; Nobili B; Jankovic M; Ramenghi U; Russo G; Zecca M; De Mattia D;
    Acta Haematol; 2008; 119(1):1-7. PubMed ID: 18176072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of chronic immune thrombocytopenic purpura in children and adults.
    Blanchette V; Freedman J; Garvey B
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):36-51. PubMed ID: 9523748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
    Watts RG
    Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic immune thrombocytopenia in childhood.
    Del Vecchio GC; De Santis A; Accettura L; De Mattia D; Giordano P
    Blood Coagul Fibrinolysis; 2014 Jun; 25(4):297-9. PubMed ID: 24492401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
    Rodeghiero F
    Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intended management of children with acute idiopathic thrombocytopenic purpura: a national survey.
    Marks MK; Vadamalayan B; Ekert H; South MJ
    J Paediatr Child Health; 2005; 41(1-2):52-5. PubMed ID: 15670225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of acute immune thrombocytopenic purpura.
    Tarantino MD; Goldsmith G
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):28-35. PubMed ID: 9523747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appropriate hospital management of adult immune thrombocytopenic purpura patients in major Italian institutions in 2000-2002: a retrospective analysis.
    Cirasino L; Robino AM; Cattaneo M; Pioltelli PE; Pogliani EM; Terranova L; Morra E; Colombo P; Palmieri GA; Piscitelli P
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):77-84. PubMed ID: 19858712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura.
    Kumar M; Vik TA; Johnson CS; Southwood ME; Croop JM
    Am J Hematol; 2005 Mar; 78(3):181-7. PubMed ID: 15726607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of initial use of intravenous immunoglobulin and prednisolone treatments in childhood idiopathic thrombocytopenic purpur.
    Ou CY; Hsieh KS; Chiou YH; Chang YH; Ger LP
    Acta Paediatr Taiwan; 2006; 47(5):226-31. PubMed ID: 17352309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How we use WinRho in patients with idiopathic thrombocytopenic purpura.
    Stotler BA; Schwartz J
    Transfusion; 2015 Nov; 55(11):2547-50. PubMed ID: 26094894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of intravenous immune globulin and high dose anti-D immune globulin as initial therapy for childhood immune thrombocytopenic purpura.
    Kane I; Ragucci D; Shatat IF; Bussel J; Kalpatthi R
    Br J Haematol; 2010 Apr; 149(1):79-83. PubMed ID: 20096011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of immune thrombocytopenic purpura in adults.
    Bussel J
    Semin Hematol; 2006 Jul; 43(3 Suppl 5):S3-10; discussion S18-9. PubMed ID: 16815346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter prospective study on the treatment of chronic idiopathic thrombocytopenic purpura.
    Dan K; Gomi S; Kuramoto A; Maekawa T; Nomura T
    Int J Hematol; 1992 Jun; 55(3):287-92. PubMed ID: 1498319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children.
    Freiberg A; Mauger D
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):23-7. PubMed ID: 9523746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical issues concerning splenectomy for chronic idiopathic thrombocytopenic purpura in childhood.
    Minkov M
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):734-6. PubMed ID: 16933270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.